Related Experiment Video
Updated: Aug 31, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Delayed medical care due to transportation barriers among US children with atopic dermatitis
David X Zheng1, Thomas B Cwalina1, Kathleen M Mulligan1
1Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
Insights
Transportation barriers delay medical care for many children with atopic dermatitis (AD). Lower socioeconomic status increases this risk, highlighting the need for targeted interventions to reduce health disparities in pediatric AD care.
Area of Science:
- Pediatric dermatology
- Health services research
- Social determinants of health
Background:
- Atopic dermatitis (AD) is a common chronic skin condition in children.
- Access to consistent medical care is crucial for managing pediatric AD.
- Transportation barriers can impede healthcare access for vulnerable populations.
Purpose of the Study:
- To determine the prevalence of delayed medical care due to transportation issues in US children with AD.
- To identify predictors of these transportation-related delays.
- To inform interventions addressing healthcare access disparities in pediatric AD.
Main Methods:
- Analysis of data from the National Health Interview Survey (1998-2018).
- Focus on a nationally representative sample of US households.
- Examination of reported instances of transport-delayed care among children diagnosed with AD.
Main Results:
- In 2018, 3.4% of US children with AD experienced transport-delayed care, affecting an estimated 279,000 children annually.
- Delayed care due to transportation was more prevalent among children from lower socioeconomic status backgrounds.
- These findings underscore significant healthcare access challenges for pediatric AD patients.
Conclusions:
- Transportation barriers represent a significant obstacle to timely medical care for children with atopic dermatitis.
- Socioeconomic status is a key predictor of these transportation-related healthcare delays.
- Interventions targeting transportation assistance are essential to mitigate health disparities in pediatric AD management.
Abstract:
Our objective was to examine the prevalence and predictors of delayed medical care due to transportation barriers among children with atopic dermatitis (AD) living in the United States (US). We analyzed data from the 1998-2018 National Health Interview Survey, a nationally representative survey of US households. In 2018, transport-delayed care was reported for 3.4% of US children with AD, representing approximately 279,000 children annually given the National Health Interview Survey's weighted survey design, and was more common among patients of lower socioeconomic status. Targeted interventions aimed at reducing transportation barriers to healthcare among at-risk AD patients may reduce health disparities related to AD.
Related Concept Videos
Specialized Care Centers and Settings-II
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma

